SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-20-049217
Filing Date
2020-04-21
Accepted
2020-04-21 16:06:01
Documents
5
Effectiveness Date
2020-04-21

Document Format Files

Seq Description Document Type Size
1 DEFA14A a20-15045_3defa14a.htm DEFA14A 32477
2 GRAPHIC g150453bci001.gif GRAPHIC 69371
3 GRAPHIC g150453bci002.gif GRAPHIC 85540
4 GRAPHIC g150453bci003.gif GRAPHIC 22875
5 GRAPHIC g150453bci004.gif GRAPHIC 4037
  Complete submission text file 0001104659-20-049217.txt   284358
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-34620 | Film No.: 20805209
SIC: 2834 Pharmaceutical Preparations